201 related articles for article (PubMed ID: 27581614)
21. Targeted and immunotherapy in the era of personalised gastric cancer treatment.
Catanese S; Lordick F
Best Pract Res Clin Gastroenterol; 2021; 50-51():101738. PubMed ID: 33975679
[TBL] [Abstract][Full Text] [Related]
22. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
Joo MK; Park JJ; Chun HJ
World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
[TBL] [Abstract][Full Text] [Related]
23. Molecular Classifications in Gastric Cancer: A Call for Interdisciplinary Collaboration.
Díaz Del Arco C; Fernández Aceñero MJ; Ortega Medina L
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473896
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy for gastric cancer: dilemmas and prospect.
Zhao Q; Cao L; Guan L; Bie L; Wang S; Xie B; Chen X; Shen X; Cao F
Brief Funct Genomics; 2019 Mar; 18(2):107-112. PubMed ID: 30388190
[TBL] [Abstract][Full Text] [Related]
25. New targeted therapies for gastric cancer.
Asaoka Y; Ikenoue T; Koike K
Expert Opin Investig Drugs; 2011 May; 20(5):595-604. PubMed ID: 21406037
[TBL] [Abstract][Full Text] [Related]
26. Innovative personalized medicine in gastric cancer: time to move forward.
Lee J; Kim KM; Kang WK; Ou SH
Clin Genet; 2014 Jul; 86(1):37-43. PubMed ID: 24749947
[TBL] [Abstract][Full Text] [Related]
27. How to stomach an epigenetic insult: the gastric cancer epigenome.
Padmanabhan N; Ushijima T; Tan P
Nat Rev Gastroenterol Hepatol; 2017 Aug; 14(8):467-478. PubMed ID: 28513632
[TBL] [Abstract][Full Text] [Related]
28. [Gastric carcinoma: an evolutionary scenario.].
Gelsomino F; Spallanzani A; De Vita F; Di Bartolomeo M; Gavazzi C; Rimassa L; Cascinu S
Recenti Prog Med; 2017 Mar; 108(3):120-127. PubMed ID: 28398405
[TBL] [Abstract][Full Text] [Related]
29. Management of advanced gastric cancer.
Price TJ; Shapiro JD; Segelov E; Karapetis CS; Pavlakis N; Van Cutsem E; Shah MA; Kang YK; Tebbutt NC
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):199-208; quiz 209. PubMed ID: 22375525
[TBL] [Abstract][Full Text] [Related]
30. Predictive biomarkers along gastric cancer pathogenetic pathways.
Panarese I; De Vita F; Ronchi A; Romano M; Alfano R; Di Martino N; Zito Marino F; Ferraraccio F; Franco R
Expert Rev Anticancer Ther; 2017 May; 17(5):417-425. PubMed ID: 28277834
[TBL] [Abstract][Full Text] [Related]
31. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.
Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O
World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L
Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer.
Zeng Y; Jin RU
Semin Cancer Biol; 2022 Nov; 86(Pt 3):566-582. PubMed ID: 34933124
[TBL] [Abstract][Full Text] [Related]
34. Microarray and next-generation sequencing to analyse gastric cancer.
Dang Y; Wang YC; Huang QJ
Asian Pac J Cancer Prev; 2014; 15(19):8033-9. PubMed ID: 25338980
[TBL] [Abstract][Full Text] [Related]
35. Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.
Sunakawa Y; Lenz HJ
Curr Treat Options Oncol; 2015 Apr; 16(4):17. PubMed ID: 25813036
[TBL] [Abstract][Full Text] [Related]
36. Geographic differences in approach to advanced gastric cancer: Is there a standard approach?
Kim R; Tan A; Choi M; El-Rayes BF
Crit Rev Oncol Hematol; 2013 Nov; 88(2):416-26. PubMed ID: 23764501
[TBL] [Abstract][Full Text] [Related]
37. Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety.
Narita Y; Muro K
Expert Opin Drug Saf; 2017 Mar; 16(3):319-327. PubMed ID: 27976952
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel genes by whole-exome sequencing can improve gastric cancer precision oncology.
Lianos GD; Glantzounis GK; Bali CD; Katsios C; Roukos DH
Future Oncol; 2017 Apr; 13(10):883-892. PubMed ID: 27897040
[TBL] [Abstract][Full Text] [Related]
39. Genetics of Gastric Cancer.
Strand MS; Lockhart AC; Fields RC
Surg Clin North Am; 2017 Apr; 97(2):345-370. PubMed ID: 28325191
[TBL] [Abstract][Full Text] [Related]
40. Gastric cancer: somatic genetics as a guide to therapy.
Zhang XY; Zhang PY
J Med Genet; 2017 May; 54(5):305-312. PubMed ID: 27609016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
